{
    "PAPER'S NUMBER OF TABLES": 2,
    "S4.T1": {
        "caption": "Table 1: Mean Dice score performance of all the experiments on the in-federation validation dataset. The standard deviation values are in parentheses. After a paired t-test, the entries underlined are significant against baseline, in bold against central agg, in italics against our best model (FedBN + FT)",
        "table": "<img src=\"/html/2301.07074/assets/int_valid_metrics.png\" id=\"S4.T1.g1\" class=\"ltx_graphics ltx_centering ltx_img_landscape\" width=\"598\" height=\"337\" alt=\"[Uncaptioned image]\">\n\n",
        "footnotes": "",
        "references": [
            "As shown in Figure 3, the FedBN model with fine-tuning performs the best on the in-federation internal validation set as well the out-of-federation BTCV test set. The SegViz framework using FedBN with fine-tuning segmented the BTCV test set with dice scores of 0.93, 0.83, 0.55, and 0.75 for segmentation of liver, spleen, pancreas, and kidneys, respectively, significantly (p<0.05ð‘0.05p<0.05) better (except spleen) than the dice scores of 0.87, 0.83, 0.42, and 0.48 for the baseline models. In contrast, the central aggregation model performed significantly (p<0.05ð‘0.05p<0.05) poorly on the test dataset with dice scores of 0.65, 0, 0.55, and 0.68. We note that the model trained on the centrally aggregated data did not generalize to the spleen label due to the overall model becoming biased toward the liver and pancreas labels, which contain more samples per label. We have included the statistical t-test results between the baseline and the best-performing models in Table 1 and Table 2."
        ]
    },
    "S5.T2": {
        "caption": "Table 2: Mean Dice score performance of all the experiments on the out-of-federation BTCV dataset. The standard deviation values are in parentheses. The same conventions as Table 1 are followed",
        "table": "<img src=\"/html/2301.07074/assets/btcv_metrics.png\" id=\"S5.T2.g1\" class=\"ltx_graphics ltx_centering ltx_img_landscape\" width=\"598\" height=\"336\" alt=\"[Uncaptioned image]\">\n\n",
        "footnotes": "",
        "references": [
            "As shown in Figure 3, the FedBN model with fine-tuning performs the best on the in-federation internal validation set as well the out-of-federation BTCV test set. The SegViz framework using FedBN with fine-tuning segmented the BTCV test set with dice scores of 0.93, 0.83, 0.55, and 0.75 for segmentation of liver, spleen, pancreas, and kidneys, respectively, significantly (p<0.05ð‘0.05p<0.05) better (except spleen) than the dice scores of 0.87, 0.83, 0.42, and 0.48 for the baseline models. In contrast, the central aggregation model performed significantly (p<0.05ð‘0.05p<0.05) poorly on the test dataset with dice scores of 0.65, 0, 0.55, and 0.68. We note that the model trained on the centrally aggregated data did not generalize to the spleen label due to the overall model becoming biased toward the liver and pancreas labels, which contain more samples per label. We have included the statistical t-test results between the baseline and the best-performing models in Table 1 and Table 2."
        ]
    }
}